Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Respirology Case Reports|August 28, 2019
Primary pleural synovial sarcoma with repeated resection leading to long-term survivalNaoko Katsurada, Hisashi Ohnishi, Miho Ikeda, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 12, 2018
Nivolumab-induced acute-onset type 1 diabetes mellitus as an immune-related adverse event: A case reportYukihisa Hatakeyama, Hisashi Ohnishi, Kentaro Suda, et al.
Respiratory Medicine Case Reports|January 7, 2021
Surgical repair of hepatic hydrothorax caused by diaphragmatic fistulaMiho Ikeda, Yukihisa Hatakeyama, Shoko Murakami, et al.
Respirology Case Reports|January 24, 2025
Unicentric Castleman's Disease of Paraspinal Origin Requiring Differentiation From Schwannoma: Case ReportHazuki Fujimoto, Kayoko Okamura, Shunsuke Tauchi, et al.
Cancer Letters|October 22, 2013
Synergistic effects of pemetrexed and amrubicin in non-small cell lung cancer cell lines: Potential for combination therapyYukihisa Hatakeyama, Kazuyuki Kobayashi, Tatsuya Nagano, et al.
Respiratory Medicine Case Reports|June 14, 2019
Endobronchial metastases 20 years after prostate cancer excisionYukihisa Hatakeyama, Sho Yoshimura, Taira Ninomaru, et al.
Thoracic Cancer|December 28, 2022
TAPO in first-line osimertinib therapy and continuation of osimertinibChihiro Mimura, Kazumi Kaneshiro, Shodai Fujimoto, et al.
Anticancer Research|August 28, 2025
Stratification by PD-L1 TPS in Advanced NSCLC With Low PD-L1 Expression for Optimizing ImmunotherapyTakafumi Fukui, Suya Hori, Yukihisa Hatakeyama, et al.
Case Reports in Pulmonology|September 1, 2012
Successful erlotinib treatment for a patient with gefitinib-related hepatotoxicity and lung adenocarcinoma refractory to intermittently administered gefitinibTatsuya Nagano, Yoshikazu Kotani, Kazuyuki Kobayashi, et al.
Internal Medicine (Tokyo, Japan)|December 22, 2011
Long-term outcome after multidisciplinary approach for leptomeningeal carcinomatosis in a non-small cell lung cancer patient with poor performance statusTatsuya Nagano, Yoshikazu Kotani, Kazuyuki Kobayashi, et al.
Pageof 2